Switch theme
Sign up to access all valuation multiples
Physitrack PLC is a digital healthcare provider, focused on B2B physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.
2012
85
LTM Revenue $195M
LTM EBITDA $53.0M
$26.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Physitrack has a last 12-month revenue (LTM) of $195M and a last 12-month EBITDA of $53.0M.
In the most recent fiscal year, Physitrack achieved revenue of $1.7M and an EBITDA of -$0.2M.
Physitrack expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Physitrack valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $195M | XXX | $1.7M | XXX | XXX | XXX |
| Gross Profit | $195M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | $53.0M | XXX | -$0.2M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | -13% | XXX | XXX | XXX |
| EBIT | -$2.7M | XXX | -$0.2M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | -12% | XXX | XXX | XXX |
| Net Profit | -$47.2M | XXX | -$0.7M | XXX | XXX | XXX |
| Net Margin | -24% | XXX | -40% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $0.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Physitrack's stock price is SEK 13 (or $1).
Physitrack has current market cap of SEK 211M (or $21.8M), and EV of SEK 256M (or $26.4M).
See Physitrack trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $26.4M | $21.8M | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Physitrack has market cap of $21.8M and EV of $26.4M.
Physitrack's trades at 15.8x EV/Revenue multiple, and -123.9x EV/EBITDA.
Equity research analysts estimate Physitrack's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Physitrack has a P/E ratio of -5.0x.
See valuation multiples for Physitrack and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $21.8M | XXX | $21.8M | XXX | XXX | XXX |
| EV (current) | $26.4M | XXX | $26.4M | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 15.8x | XXX | XXX | XXX |
| EV/EBITDA | 5.4x | XXX | -123.9x | XXX | XXX | XXX |
| EV/EBIT | -107.9x | XXX | -127.1x | XXX | XXX | XXX |
| EV/Gross Profit | 1.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -5.0x | XXX | -32.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -703.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPhysitrack's last 12 month revenue growth is 1%
Physitrack's revenue per employee in the last FY averaged $20K, while opex per employee averaged $22K for the same period.
Physitrack's rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Physitrack's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Physitrack and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 243% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | -13% | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | 172% | XXX | XXX | XXX |
| Rule of 40 | 47% | XXX | -12% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $20K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $22K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 112% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedAdvisor | XXX | XXX | XXX | XXX | XXX | XXX |
| Oneview Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Brain+ | XXX | XXX | XXX | XXX | XXX | XXX |
| Sphere | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Physitrack acquired XXX companies to date.
Last acquisition by Physitrack was XXXXXXXX, XXXXX XXXXX XXXXXX . Physitrack acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Physitrack founded? | Physitrack was founded in 2012. |
| Where is Physitrack headquartered? | Physitrack is headquartered in Sweden. |
| How many employees does Physitrack have? | As of today, Physitrack has 85 employees. |
| Is Physitrack publicy listed? | Yes, Physitrack is a public company listed on STO. |
| What is the stock symbol of Physitrack? | Physitrack trades under PTRK ticker. |
| When did Physitrack go public? | Physitrack went public in 2021. |
| Who are competitors of Physitrack? | Similar companies to Physitrack include e.g. MedAdvisor, Oneview Healthcare, Brain+, Sphere. |
| What is the current market cap of Physitrack? | Physitrack's current market cap is $21.8M |
| What is the current revenue of Physitrack? | Physitrack's last 12 months revenue is $195M. |
| What is the current revenue growth of Physitrack? | Physitrack revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Physitrack? | Current revenue multiple of Physitrack is 1.5x. |
| Is Physitrack profitable? | Yes, Physitrack is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Physitrack? | Physitrack's last 12 months EBITDA is $53.0M. |
| What is Physitrack's EBITDA margin? | Physitrack's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Physitrack? | Current EBITDA multiple of Physitrack is 5.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
